By combining next generation computing power with the clinical expertise of a certified CAP/CLIA lab, Breakthrough Genomics tests deliver high diagnostic yields with fast turnaround times.
Breakthrough Genomics works with healthcare providers, research institutions, and partner organizations to provide genetic tests both in the U.S. and around the world.
The company has also developed a first-of-its-kind bioinformatic platform called Virtual Geneticist that leverages the power of AI to help users quickly zero in on the correct disease-causing variants
Breakthrough Genomics offers a wide range of advanced genetic tests from hereditary cancer and cardiovascular screening to rare disease diagnosis and rapid Whole Genome and Whole Exome tests for the NICU and PICU.
The company’s early cancer detection tests revolutionize screening for a range of cancers, including pancreatic cancer, colon cancer, stomach cancer, liver cancer, and more, using just a simple tube of blood. These tests have received prestigious recognition, including the FDA Breakthrough Device grant and the EU IVDD certificate.
Breakthrough Genomics leverages the company’s proprietary technology and hands-on experience in clinical genomics to help solve the biggest challenges
in precision medicine.
(949)-220-2325